Daewoong pharmaceutical (069620.KS) Dividend: History, Dates & Yield - 2024
Dividend History
Daewoong pharmaceutical announced a annually dividend of ₩600.00 per ordinary share, payable on 2025-04-14, with an ex-dividend date of 2024-12-27. Daewoong pharmaceutical typically pays dividends one times a year, compared to ₩600.00 in 2024.
Find details on Daewoong pharmaceutical's dividend performance with a comprehensive history of past and upcoming payments.
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | ₩600.00 | annually | 2025-04-14 |
2022-12-28 | ₩600.00 | annually | 2023-04-07 |
2021-12-29 | ₩600.00 | annually | 2022-04-08 |
2020-12-29 | ₩600.00 | annually | 2021-04-09 |
2019-12-27 | ₩600.00 | annually | 2020-04-16 |
2018-12-27 | ₩600.00 | annually | 2019-04-19 |
2017-12-27 | ₩600.00 | annually | 2018-04-20 |
2016-12-28 | ₩600.00 | annually | |
2015-12-29 | ₩700.00 | annually | |
2014-12-29 | ₩700.00 | annually |
Dividend Increase
, while over the last ten years (2015-2024), it was -2.68% per year. In comparison, 000100.KS has seen an average growth rate of -13.64% over the past five years and Green Cross's growth rate was 11.31%.
By comparing Daewoong pharmaceutical's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Daewoong pharmaceutical's current trailing twelve-month (TTM) dividend yield is 0.46%. Over the last 12 months, Daewoong pharmaceutical has maintained this yield, but how does it compare to similar stocks? For example, 000100.KS offers a yield of 0.32%, while Green Cross provides a yield of 1.02%. Comparing similar stocks can help investors assess Daewoong pharmaceutical's yield and make more informed decisions.
Company | Dividend Yield | Annual Dividend | Stock Price |
---|---|---|---|
Daewoong pharmaceutical (069620.KS) | 0.46% | ₩600 | ₩130000 |
000100.KS (000100.KS) | 0.32% | $428.57101 | $134000 |
Green Cross (006280.KS) | 1.02% | ₩1500 | ₩146400 |
Dividend Yield Calculator
Interested in purchasing Daewoong pharmaceutical stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Daewoong pharmaceutical has a payout ratio of 0.01%. In comparison, 000100.KS has a payout ratio of 0.18%, while Green Cross's payout ratio is -0.23%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Daewoong pharmaceutical
Frequently Asked Question
Other factors to consider when evaluating Daewoong pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Daewoong pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Daewoong pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Daewoong pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Daewoong pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Daewoong pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Daewoong pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Daewoong pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Daewoong pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Daewoong pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Daewoong pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.